No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
180 |
4. Check minimum number of eventsNone |
180 |
5. Include endpointsNone |
180 |
6. Filter based on genotype QC (FinnGen only) |
180 |
Control definitions (FinnGen only)
- Control exclude
- F5_DEMENTIA, G6_ALZHEIMER, G6_AD_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Frontotemporal dementia
based on the number of shared cases.
Similar with more cases:
- Frontotemporal dementia, wide, incl. Pick's disease
- Circumscribed brain atrophy
- Dementia in other diseases classified elsewhere
- Degenerative diseases of the nervous system
- Other degenerative diseases of the nervous system
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2112 | 1189 | 909 |
| Only index persons | 1877 | 1084 | 793 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 71.43 | 72.17 | 70.41 |
| Only index persons | 71.37 | 72.13 | 70.33 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 180 | 79 | 101 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | 69.65 | 70.57 | 68.94 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 148
- Matched controls
- 1480
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
141.1
112
*
G31.0
ICD-10 Finland
Circumscribed brain atrophy
619.6
74.8
68
*
F03
ICD-10 Finland
Unspecified dementia
94.0
43.0
46
7
N05AX08
ATC
risperidone; systemic
28.2
40.3
56
31
N05AH04
ATC
quetiapine; oral
17.0
39.8
69
72
N05AH03
ATC
olanzapine; systemic
28.8
28.8
39
18
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
12.3
27.3
53
64
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
10.9
27.2
57
80
N03AG01
ATC
valproic acid; systemic, rectal
17.3
26.5
43
34
F02.09
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
25.8
24
*
TAB00
NOMESCO Finland
Lumbar puncture
17.8
25.1
40
30
N06DA02
ATC
donepezil; oral
283.5
24.4
24
*
P70
ICPC
Dementia
148.9
24.4
25
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
15.1
22.4
38
33
N06DX01
ATC
memantine; oral
255.8
22.2
22
*
XA800
NOMESCO Finland
Neuropsychological investigation
21.1
21.7
32
19
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
14.9
20.6
35
30
N05BA06
ATC
lorazepam; systemic, sublingual
18.2
20.5
32
22
F0203, G310
ICD-10 Finland
NA
+∞
18.1
17
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
101.6
16.9
18
*
F06.7
ICD-10 Finland
Mild cognitive disorder
24.4
16.6
23
11
P20
ICPC
Memory disturbance
5.9
15.9
50
118
A28
ICPC
Limited function/disability NOS
5.1
15.6
59
171
F0204, G310
ICD-10 Finland
NA
+∞
14.8
14
*
F0200, G310
ICD-10 Finland
NA
+∞
13.7
13
*
N06DA03
ATC
rivastigmine; oral, transdermal
153.2
13.7
14
*
N06AX11
ATC
mirtazapine; oral
4.0
13.0
68
261
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
12.7
12
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
51.1
12.1
14
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
+∞
11.6
11
*
N05BA04
ATC
oxazepam; oral
3.8
11.0
56
204
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
8.9
10.9
23
30
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
117.8
10.6
11
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
25.5
10.4
14
6
N06AB10
ATC
escitalopram; oral
4.4
10.0
39
111
IGY99
NOMESCO Finland
Other psychiatric treatment contact
58.8
9.8
11
*
RT250
NOMESCO Finland
NA
106.3
9.5
10
*
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
+∞
9.5
9
*
F0202, G310
ICD-10 Finland
NA
+∞
9.5
9
*
N06AX16
ATC
venlafaxine; oral
4.8
9.3
32
80
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
39.2
9.1
11
*
R41.0
ICD-10 Finland
Disorientation, unspecified
9.6
9.1
18
21
G30.1
ICD-10 Finland
Alzheimer disease with late onset
25.9
9.1
12
5
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.7
9.0
26
53
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.9
9.0
25
49
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
8.5
9.0
19
25
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
53.1
8.8
10
*
P99
ICPC
Psychological disorders other
29.4
8.6
11
*
RT150
NOMESCO Finland
NA
95.1
8.5
9
*
F06.4
ICD-10 Finland
Organic anxiety disorder
95.1
8.5
9
*
F0201, G310
ICD-10 Finland
NA
+∞
8.4
8
*
N05AD01
ATC
haloperidol; systemic
10.3
8.0
15
16
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.5
7.8
28
73
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
47.4
7.8
9
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
47.4
7.8
9
*
F05.9
ICD-10 Finland
Delirium, unspecified
10.9
7.7
14
14
N05AX12
ATC
aripiprazole; systemic
26.5
7.7
10
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.1
7.5
*
271
G30.8
ICD-10 Finland
Other Alzheimer disease
84.0
7.5
8
*
R41.3
ICD-10 Finland
Other amnesia
10.2
7.5
14
15
F064, G310
ICD-10 Finland
NA
+∞
7.3
7
*
G30.0
ICD-10 Finland
Alzheimer disease with early onset
+∞
7.3
7
*
F22.0
ICD-10 Finland
Delusional disorder
16.8
7.3
11
7
SPAT1234
SPAT
Support of social functional capacity
5.5
7.3
21
43
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
21.2
7.2
10
5
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
31.6
7.2
9
*
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
41.9
6.8
8
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
8.4
6.8
14
18
AA1AD
NOMESCO Finland
CT of head and brain
2.6
6.6
60
304
N06AB04
ATC
citalopram; systemic
3.0
6.6
42
171
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
72.7
6.5
7
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
5.4
6.3
18
37
P72
ICPC
Schizophrenia
27.9
6.3
8
*
F060, G310
ICD-10 Finland
NA
+∞
6.3
6
*
G12.2
ICD-10 Finland
Motor neuron disease
+∞
6.3
6
*
N05AH02
ATC
clozapine; systemic
+∞
6.3
6
*
F020, G310
ICD-10 Finland
NA
+∞
6.3
6
*
F02.00
ICD-10 Finland
Dementia in Pick's disease without additional symptoms
+∞
6.3
6
*
N03AX09
ATC
lamotrigine; oral
8.2
6.3
13
17
R53
ICD-10 Finland
Malaise and fatigue
2.8
6.3
44
193
F29
ICD-10 Finland
Unspecified nonorganic psychosis
13.3
6.2
10
8
A04
ICPC
Weakness/tiredness general
3.3
6.2
33
119
P76
ICPC
Depressive disorder
10.7
6.1
11
11
SPAT1216
SPAT
Assessment of functional ability
2.8
6.0
43
190
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
29
11
31.23
42.69
1.0
1.0
ng/l
838.2
552.8
—
20
5
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
29
28
12.15
26.95
1.1
1.2
e6/l
1.6
3.6
1.67
21
22
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
28
28
11.66
25.37
1.1
1.4
e6/l
125.5
111.0
0.04
20
22
(3023410) Appearance of Cerebral spinal fluid
17
10
18.67
20.54
1.4
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
79
306
3.82
17.07
2.0
1.7
nmol/l
1287.6
1189.2
0.42
61
228
(3044290) Cell count panel - Cerebral spinal fluid
20
25
8.88
15.20
1.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
11
11.62
11.18
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
31
6.34
10.28
1.2
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
31
6.34
10.28
1.2
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
103
627
2.50
8.32
2.9
2.0
pmol/l
89.9
95.5
0.64
58
319
(3015377) Calcium [Moles/volume] in Serum or Plasma
89
507
2.49
8.30
2.6
3.3
mmol/l
2.4
2.4
0.09
73
437
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
61
297
2.59
7.87
3.2
3.2
mmol/l
2.4
2.5
1.01
46
252
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
38
146
3.03
7.65
2.5
2.5
u/l
35.2
37.3
0.10
33
117
(3033658) Prothrombin time (PT) actual/Normal
68
374
2.31
6.53
4.1
3.9
%
88.6
87.1
0.18
63
365
(3019832) Treponema pallidum Ab [Presence] in Serum
14
31
4.81
6.10
1.0
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40
179
2.59
5.98
1.9
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
80
487
2.16
5.87
3.6
4.0
ph
7.4
7.4
—
10
101
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
39
175
2.57
5.79
1.9
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
189
2.51
5.76
11.3
8.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
59
323
2.23
5.61
4.6
3.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
28
113
2.75
5.09
2.6
1.7
%
1.4
1.7
1.28
23
94
(1761868) Lipid panel - Serum or Plasma
17
440
0.32
5.09
2.1
3.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
64
375
2.10
5.04
6.7
6.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
52
283
2.18
4.94
3.0
3.0
e6/l
1.3
1.0
0.30
24
165
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
101
702
2.00
4.92
7.4
5.7
mmol/l
1.2
1.2
0.11
89
632
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
28
4.52
4.90
1.1
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
64
380
2.06
4.84
1.8
1.6
nmol/l
20.4
20.5
0.02
58
316
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
35
3.93
4.45
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
48
263
2.13
4.44
2.9
3.2
e6/l
7.2
2.9
0.58
20
147
(3000991) Gas panel - Venous blood
30
137
2.43
4.25
5.1
7.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
69
438
1.93
4.22
3.9
3.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
45
248
2.09
4.08
1.9
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
92
652
1.84
3.93
4.2
4.8
g/l
35.4
35.0
0.29
80
613
(3041096) Erythrocytes [Presence] in Urine by Automated
18
402
0.39
3.78
4.4
4.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
83
579
1.80
3.66
3.9
3.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
15
52
3.06
3.56
4.2
3.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
0
88
0.00
3.40
0.0
4.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
69
466
1.78
3.33
3.9
3.3
e6/l
0.3
0.6
1.08
52
348
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
16
60
2.83
3.33
2.1
2.9
pmol/l
4.0
4.3
—
10
55
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
70
476
1.77
3.29
2.6
2.0
u/l
433.2
249.8
0.56
62
443
(3022217) INR in Platelet poor plasma by Coagulation assay
40
231
1.94
3.14
16.4
24.6
—
1.3
—
0
26
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
101
769
1.71
3.13
7.7
6.6
mmol/l
1.2
1.2
0.51
82
644
(3028707) Methadone [Presence] in Urine by Screen method
5
5
10.23
2.99
1.2
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
68
470
1.72
2.96
4.1
3.3
—
—
—
0
0
(3013512) EKG study
30
488
0.54
2.50
3.2
4.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
70
508
1.62
2.45
3.8
3.5
e6/l
33.4
195.0
0.69
50
394
(3020682) Albumin/Creatinine [Ratio] in Urine
33
517
0.56
2.40
3.5
4.1
mg/mmol
5.6
9.8
0.85
25
326
(3012095) Magnesium [Moles/volume] in Serum or Plasma
42
270
1.72
2.32
3.0
3.2
mmol/l
0.8
0.8
0.07
35
251
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
55
381
1.64
2.30
2.8
2.1
mg/l
3.3
3.2
0.08
48
339
(3003338) MCHC [Mass/volume]
129
1096
1.62
2.24
32.7
22.1
g/l
330.0
331.5
0.86
122
1090
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
9
5.68
2.23
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
88
2.16
2.20
1.9
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
75
567
1.55
2.15
4.6
4.1
e6/l
115.3
82.1
0.22
53
419
(3023368) Bacteria identified in Blood by Culture
63
459
1.57
2.12
5.0
4.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
10
5.11
2.08
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
10
5.11
2.08
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
187
0.40
2.08
1.0
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
47
322
1.62
2.03
3.1
3.0
mosm/kgh2o
541.8
543.4
0.02
42
272
(3027944) Amphetamines [Presence] in Urine
5
11
4.64
1.95
1.2
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
11
4.64
1.95
1.2
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
11
4.64
1.95
1.2
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
117
990
1.52
1.90
5.0
4.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
53
0.00
1.90
0.0
5.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
12
4.25
1.83
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
33
485
0.61
1.81
3.0
3.3
mg/l
28.0
188.2
0.67
26
318
(3003694) ABO and Rh group [Type] in Blood
21
347
0.55
1.79
1.2
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
47
0.00
1.73
0.0
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
31
199
1.67
1.71
11.1
6.9
mmol/l
0.8
1.1
0.07
25
162
(3021440) Promyelocytes/100 leukocytes in Blood
5
133
0.36
1.70
2.0
4.4
—
0.2
—
0
45
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
56
2.22
1.65
2.3
1.9
u/ml
0.4
0.4
—
7
26
(3020891) Body temperature
13
63
2.15
1.64
19.1
3.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
118
1019
1.46
1.59
5.7
3.9
pmol/l
13.9
15.1
4.80
105
891
(3025159) Blasts/100 leukocytes in Blood
5
125
0.38
1.57
2.0
4.4
—
0.0
—
0
37
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
124
1376
0.68
1.52
3.9
5.0
mmol/l
1.4
1.5
1.29
106
1236
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
16
87
1.92
1.51
5.3
6.1
mmol/l
26.6
24.8
1.06
16
87
(3002179) Metamyelocytes/100 leukocytes in Blood
5
124
0.39
1.43
2.0
4.1
—
0.4
—
0
32
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
123
1359
0.70
1.37
6.1
6.7
mmol/mol
40.3
41.1
0.36
113
1253
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
12
61
2.04
1.36
2.4
2.2
g/l
42.1
36.8
—
6
52
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
38
0.00
1.36
0.0
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
127
1395
0.70
1.36
5.1
5.2
mmol/l
6.2
6.1
0.30
114
1256
(3009542) Hematocrit [Volume Fraction] of Blood
131
1170
1.44
1.36
28.2
17.8
%
39.4
39.5
0.05
91
752
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
126
1384
0.70
1.32
4.0
5.0
mmol/l
4.6
4.5
0.20
107
1253
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
12
62
2.00
1.31
2.4
2.6
g/l
1.3
0.6
—
7
54
(3021387) Prolactin [Units/volume] in Serum or Plasma
5
18
2.83
1.29
1.2
1.6
mu/l
159.6
295.3
—
5
18
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
25
164
1.61
1.29
3.2
2.4
ug/l
8.8
9.1
0.02
18
147
(3019198) Lymphocytes [#/volume] in Blood
86
724
1.36
1.23
5.0
5.8
e9/l
1.6
2.0
1.38
71
638
(3051611) Lipemic interference index of Serum or Plasma
5
19
2.68
1.22
5.4
2.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
126
0.46
1.22
1.2
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
119
1.67
1.17
1.3
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
35
0.00
1.16
0.0
2.6
—
—
—
0
0
(3012544) pH of Venous blood
23
152
1.59
1.16
2.1
3.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
84
710
1.34
1.15
5.0
5.7
e9/l
0.6
0.6
0.09
66
606
(40761535) Cells panel - Urine sediment
20
128
1.63
1.14
4.5
3.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
128
1154
1.38
1.14
7.3
8.0
u/l
83.0
80.3
0.23
112
1082
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
54
664
0.73
1.10
3.1
4.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
46
579
0.72
1.08
1.9
2.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
84
715
1.33
1.08
5.0
5.7
e9/l
0.0
0.0
0.32
69
613
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
131
1416
0.73
1.08
4.7
5.7
mmol/l
2.7
2.6
0.24
114
1276
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
19
122
1.62
1.07
3.2
3.4
ng/l
85.2
84.5
0.02
13
109
(40768797) Stomach Pathology biopsy report
13
212
0.58
1.06
1.5
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
86
736
1.32
1.06
6.6
5.8
e9/l
0.2
0.2
0.31
72
644
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
123
1340
0.74
1.04
3.5
4.4
mmol/l
1.4
1.3
1.51
103
1197
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
135
0.50
1.03
1.6
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
35
2.04
1.01
1.3
2.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
30
0.00
0.98
0.0
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
30
0.00
0.98
0.0
1.1
—
23.1
—
0
25
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
77
1.74
0.98
2.5
2.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
299
1.39
0.97
4.1
3.7
ng/l
62.1
135.4
0.96
34
253
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
31
0.00
0.97
0.0
2.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
23
159
1.51
0.97
1.7
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
70
1.77
0.95
2.4
2.2
g/l
2.9
3.3
—
7
55
(42870588) Differential panel, method unspecified - Blood
59
485
1.32
0.95
4.9
5.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
154
0.56
0.93
1.1
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
67
562
1.31
0.93
2.6
2.3
nmol/l
74.1
79.6
1.00
55
489
(3013650) Neutrophils [#/volume] in Blood by Automated count
96
846
1.29
0.91
9.1
9.5
e9/l
4.8
4.2
1.05
79
733
(3042936) Bacteria identified in Isolate by Culture
16
238
0.64
0.91
2.0
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
72
1.71
0.87
2.4
2.0
g/l
8.4
10.2
—
6
63
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
92
812
1.27
0.84
5.8
3.5
u/l
63.5
57.2
0.15
84
739
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
23
165
1.45
0.83
2.0
3.5
umol/l
7.9
9.3
0.18
18
145
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
74
638
1.27
0.82
2.9
2.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
24
0.00
0.80
0.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
26
0.00
0.79
0.0
2.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
27
0.00
0.78
0.0
2.6
—
4.6
—
0
27
(3041354) Potassium [Moles/volume] in Venous blood
0
27
0.00
0.78
0.0
2.4
—
4.1
—
0
27
(3035285) Chloride [Moles/volume] in Venous blood
0
27
0.00
0.78
0.0
2.4
—
106.4
—
0
27
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
28
0.00
0.77
0.0
2.7
—
61.2
—
0
28
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
16
228
0.67
0.75
1.3
1.3
iu/ml
20.9
48.0
—
5
82
(3020564) Creatinine [Moles/volume] in Serum or Plasma
141
1488
0.76
0.75
24.8
20.2
umol/l
76.5
82.6
2.07
141
1488
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
137
1280
1.29
0.74
6.8
4.7
mu/l
2.9
2.0
0.68
118
1125
(3027945) Reticulocytes/100 erythrocytes in Blood
26
196
1.38
0.73
1.7
3.0
%
1.6
1.7
0.26
21
177
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
42
1.69
0.69
1.4
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
78
1.58
0.67
2.4
2.1
g/l
4.9
3.8
—
7
54
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
78
1.58
0.67
2.4
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
78
1.58
0.67
2.4
2.1
g/l
7.2
7.8
—
7
56
(4146454)
0
20
0.00
0.60
0.0
3.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
20
0.00
0.60
0.0
1.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
75
666
1.22
0.60
5.4
5.9
%
60.3
58.4
0.66
68
621
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
42
350
1.26
0.60
1.4
1.8
pmol/l
459.9
446.3
0.11
33
290
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
21
0.00
0.60
0.0
3.3
—
28.6
—
0
5
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
146
1387
1.28
0.60
21.8
16.5
mg/l
31.9
25.5
1.28
111
1123
(3042631) Mycobacterium sp identified in Specimen
0
22
0.00
0.59
0.0
4.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
62
541
1.22
0.59
2.9
2.7
ug/l
90.4
158.6
3.23
53
493
(3019060) Gas panel - Arterial blood
16
115
1.43
0.59
13.8
4.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
23
0.00
0.58
0.0
1.1
—
6.4
—
0
8
(46235355) HIV 1 and 2 tests - Meaningful Use set
18
133
1.39
0.57
1.0
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
178
1.33
0.56
3.6
3.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
24
301
0.77
0.54
2.3
5.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
75
672
1.20
0.54
5.3
6.2
%
24.8
26.3
0.54
66
623
(3022096) Basophils/100 leukocytes in Blood
72
644
1.20
0.53
5.5
6.0
%
0.7
0.6
0.30
64
601
(40768443) Skin Pathology biopsy report
9
64
1.43
0.52
1.2
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
47
404
1.22
0.52
5.8
4.3
estimate
0.0
0.0
—
7
140
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
11
76
1.48
0.49
1.1
1.3
—
28.8
—
0
5
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
50
1.42
0.45
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
50
1.42
0.45
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
50
1.42
0.45
1.3
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
89
820
1.17
0.45
5.0
6.7
umol/l
10.4
11.8
0.85
80
781
(3006504) Eosinophils/100 leukocytes in Blood
73
662
1.17
0.45
5.4
5.9
%
2.8
2.7
0.21
65
617
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
205
0.76
0.43
1.5
1.3
u/ml
1.9
15.5
—
6
78
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
96
1.38
0.43
1.5
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
73
665
1.16
0.42
5.5
6.2
%
8.8
8.8
0.04
64
623
(3012441) Differential panel - Pleural fluid
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
15
0.00
0.41
0.0
2.1
—
0.9
—
0
6
(3004775) Volume in Urine collected for unspecified duration
0
15
0.00
0.41
0.0
2.3
—
492.6
—
0
7
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
16
0.00
0.41
0.0
1.4
—
319.9
—
0
16
(4268621)
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
129
1348
0.85
0.41
20.8
15.9
ml/min/173m2
76.3
73.6
0.92
107
1100
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
17
0.00
0.41
0.0
3.3
—
62.8
—
0
9
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
17
0.00
0.41
0.0
1.1
—
7.1
—
0
11
(4306422)
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
70
637
1.16
0.40
4.1
4.2
ng/l
28.0
45.1
1.34
52
507
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
60
663
0.86
0.40
4.8
5.3
ug/l
2.0
2.9
0.68
50
586
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
18
0.00
0.40
0.0
5.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
36
415
0.83
0.40
2.3
3.1
umol/l
355.7
7019.9
1.73
24
339
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
39
340
1.19
0.38
2.2
2.5
—
—
—
0
0
(4010399)
9
122
0.72
0.36
1.4
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
42
1.44
0.36
2.8
4.0
—
—
—
0
0
(3002256) Pathology report gross observation
15
188
0.78
0.35
1.1
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
16
127
1.29
0.35
2.1
2.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
29
249
1.20
0.33
1.4
2.2
g/l
2.3
2.3
0.03
21
229
(3019225) pH of Specimen
11
142
0.76
0.32
4.4
4.0
—
—
—
0
0
(4034850)
7
52
1.36
0.31
10.4
11.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
31
270
1.18
0.31
1.5
2.2
umol/l
11.3
13.2
0.85
24
246
(3021601) Nitrite [Presence] in Urine by Test strip
77
718
1.13
0.30
5.5
5.6
estimate
0.0
0.0
—
8
151
(40761536) Microorganisms panel - Urine sediment
10
129
0.76
0.29
6.1
4.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
15
182
0.81
0.28
1.3
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
110
1052
1.12
0.27
3.9
4.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
145
1488
0.87
0.26
12.5
11.7
u/l
24.1
24.8
0.24
135
1425
(3035350) Ketones [Presence] in Urine by Test strip
76
713
1.11
0.26
4.7
4.2
estimate
0.0
0.0
—
8
151
(3009261) Glucose [Presence] in Urine by Test strip
77
724
1.11
0.25
4.6
4.2
estimate
0.0
0.0
—
7
143
(3013826) Glucose [Moles/volume] in Serum or Plasma
94
894
1.11
0.25
8.4
4.9
mmol/l
7.2
6.9
0.77
82
840
(3049717) Cytology report of Urine Cyto stain
6
81
0.73
0.24
2.8
3.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
36
325
1.13
0.23
1.9
1.8
mg/l
1.4
1.4
0.03
26
262
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
52
560
0.90
0.22
5.4
4.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
2.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.3
—
14.8
—
0
12
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
43
1.17
0.21
1.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
15.2
—
0
13
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
48
1.26
0.20
1.0
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
17
146
1.18
0.20
2.1
2.8
g/l
67.3
66.5
—
10
132
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
61
1.15
0.18
1.9
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
118
1146
1.09
0.17
29.2
20.7
%
14.0
13.9
0.13
110
1124
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
119
0.83
0.16
1.4
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
90
0.77
0.15
2.4
8.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
146
1434
1.10
0.14
18.2
15.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
151
1488
1.09
0.12
28.6
19.5
mmol/l
139.7
139.7
0.08
141
1450
(3035941) MCH [Entitic mass]
150
1521
0.92
0.12
32.3
24.1
pg
30.4
30.5
0.18
142
1497
(3026361) Erythrocytes [#/volume] in Blood
150
1521
0.92
0.12
32.5
24.2
e12/l
4.3
4.5
2.50
141
1468
(3024731) MCV [Entitic volume]
150
1521
0.92
0.12
32.4
24.1
fl
91.9
91.7
0.19
142
1497
(3010813) Leukocytes [#/volume] in Blood
150
1521
0.92
0.12
32.5
24.2
e9/l
7.0
6.8
0.70
141
1465
(3000963) Hemoglobin [Mass/volume] in Blood
150
1521
0.92
0.12
32.5
24.3
g/l
130.7
134.6
2.26
142
1494
(3021589) Normoblasts [#/volume] in Blood
69
664
1.06
0.12
8.3
11.2
e9/l
0.0
0.0
0.58
51
542
(3007461) Platelets [#/volume] in Blood
150
1520
0.92
0.11
32.4
24.2
e9/l
245.9
241.1
0.37
141
1475
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
125
0.87
0.10
1.4
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
47
1.07
0.09
1.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
5
47
1.07
0.09
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
151
1492
1.07
0.09
27.6
19.6
mmol/l
4.0
4.0
1.58
141
1457
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
75
1.07
0.07
4.9
2.4
%
1.3
1.1
—
8
75
(3007164) IgA [Mass/volume] in Serum or Plasma
24
255
0.93
0.07
1.6
1.4
g/l
2.3
2.4
0.16
12
150
(3008152) Bicarbonate [Moles/volume] in Arterial blood
12
109
1.11
0.06
35.9
6.6
mmol/l
25.4
24.6
0.42
12
104
(3032080) INR in Blood by Coagulation assay
69
678
1.03
0.03
5.2
10.3
inr
1.1
1.3
3.10
11
213
(3044640) Blood type and Crossmatch panel - Blood
45
461
0.97
0.03
2.6
2.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
55
561
0.97
0.03
2.7
3.2
ng/l
708.5
1574.4
2.93
49
483
(3000492) Spirometry study
12
127
0.94
0.01
1.3
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
48
472
1.02
0.01
2.9
2.5
u/l
45.2
58.4
2.87
42
434
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
38
387
0.98
0.01
2.4
3.2
ug/l
0.9
0.8
0.08
32
272
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
13
136
0.95
0.00
1.6
2.9
ng/l
148.3
220.2
0.50
13
119
(3013707) Erythrocyte sedimentation rate by Westergren method
105
1056
0.99
0.00
3.2
4.5
mm/h
13.5
14.2
0.20
94
959
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
54
538
1.01
0.00
3.8
4.7
%
22.6
22.1
0.09
20
283
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
27
275
0.98
0.00
1.4
1.2
u/ml
0.6
1.5
—
7
72
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
53
0.94
0.00
1.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
11.7
—
0
5
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
1.3
—
0
6
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(4024509)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
14.8
—
0
9
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
17.3
—
0
6
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
5
0.00
0.00
0.0
2.6
—
84.2
—
0
5
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.0
—
4.4
—
0
6
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
0.8
—
0
5
(3016244) Insulin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
7.2
—
0
5
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
41.0
—
0
5
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.8
—
212.5
—
0
8
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
51
0.98
0.00
1.0
1.8
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
7
0.00
0.00
0.0
6.1
—
41.6
—
0
7
(3025941) Bacteria identified in Stool by Culture
8
80
1.00
0.00
1.3
1.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.1
—
6.6
—
0
7
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
83
0.96
0.00
1.3
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
2.3
—
90.9
—
0
7
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
84.0
—
0
7
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint FTD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| FTD | 3.562 [2.87, 4.42] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.253 |
During the follow-up period (1.1.1998 — 31.12.2019), 577 out of 1114 females with FTD died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| FTD | 4.074 [3.11, 5.33] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.017 |
During the follow-up period (1.1.1998 — 31.12.2019), 493 out of 822 males with FTD died.
Mortality risk
Mortality risk for people of age
years, who have FTD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.343% | 0.872% |
| 5 | 2.068% | 5.012% |
| 10 | 5.094% | 12.523% |
| 15 | 9.351% | 21.829% |
| 20 | 15.906% | 34.13% |
Relationships between endpoints
↥Index endpoint: FTD – Frontotemporal dementia
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data